Skip to Main Content

Latest News from Health Policy & Management

Not all hypertension drugs are created equal, reports big-data study

For those with extremely high blood pressure, or hypertension, there are many initial medication options — so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best choice for initial treatment.

Read more